Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

Beyond the GFAP-astrocyte protein markers in the brain

AM Jurga, M Paleczna, J Kadluczka, KZ Kuter - Biomolecules, 2021 - mdpi.com
The idea of central nervous system as one-man band favoring neurons is long gone. Now
we all are aware that neurons and neuroglia are team players and constant communication …

The two-century journey of Parkinson disease research

S Przedborski - Nature Reviews Neuroscience, 2017 - nature.com
Since the first formal description of Parkinson disease (PD) two centuries ago, our
understanding of this common neurodegenerative disorder has expanded at all levels of …

[HTML][HTML] Iron in neurodegeneration–cause or consequence?

A Ndayisaba, C Kaindlstorfer… - Frontiers in neuroscience, 2019 - frontiersin.org
Iron dyshomeostasis can cause neuronal damage to iron-sensitive brain regions.
Neurodegeneration with brain iron accumulation reflects a group of disorders caused by iron …

Astrocytes: biology and pathology

MV Sofroniew, HV Vinters - Acta neuropathologica, 2010 - Springer
Astrocytes are specialized glial cells that outnumber neurons by over fivefold. They
contiguously tile the entire central nervous system (CNS) and exert many essential complex …

Baicalein attenuates neuroinflammation by inhibiting NLRP3/caspase-1/GSDMD pathway in MPTP-induced mice model of Parkinson's disease

W Rui, S Li, H Xiao, M Xiao, J Shi - International Journal of …, 2020 - academic.oup.com
Background Inflammasome-induced neuroinflammation is a major pathogenic mechanism
underlying the degeneration of nigral dopaminergic neurons in Parkinson's disease (PD) …

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

EC Hirsch, S Hunot - The Lancet Neurology, 2009 - thelancet.com
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …

Neuron-astrocyte interactions in Parkinson's disease

I Miyazaki, M Asanuma - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease. PD
patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural …

[HTML][HTML] Microglia response during Parkinson's disease: alpha-synuclein intervention

SA Ferreira, M Romero-Ramos - Frontiers in cellular neuroscience, 2018 - frontiersin.org
The discovery of the central role played by the protein alpha-synuclein in Parkinson's
disease and other Lewy body brain disorders has had a great relevance in the …

Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

W Zhang, T Wang, Z Pei, DS Miller, X Wu… - The FASEB …, 2005 - Wiley Online Library
ABSTRACT A growing body of evidence indicates that an inflammatory process in the
substantia nigra, characterized by activation of resident microglia, likely either initiates or …